ERLOTINIB HYDROCHLORIDE

ERLOTINIB HYDROCHLORIDE was reported 12479 times

ERLOTINIB HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ERYTHEMA DYSCHROMICUM PERSTANS 21 0.3962
1 LARYNGEAL PAPILLOMA 12 0.2553
2 TRICHOMEGALY 11 0.2500
3 RESPIRATORY PAPILLOMA 12 0.2182
4 EGFR GENE MUTATION 69 0.1845
5 NAEVOID MELANOMA 7 0.1707
6 EROSIVE PUSTULAR DERMATOSIS 7 0.1400
7 CONJUNCTIVAL ULCER 11 0.0797
8 MALIGNANT TRANSFORMATION 24 0.0535
9 ACQUIRED GENE MUTATION 66 0.0503
10 LUNG ADENOCARCINOMA STAGE IV 19 0.0499
11 ALOPECIA SCARRING 9 0.0492
12 LUNG ADENOCARCINOMA METASTATIC 11 0.0472
13 PNEUMOPERICARDIUM 8 0.0465
14 BRONCHIAL FISTULA 9 0.0446
15 NON-SMALL CELL LUNG CANCER METASTATIC 39 0.0444
16 METASTASES TO THORAX 11 0.0435
17 PERSISTENT CORNEAL EPITHELIAL DEFECT 5 0.0424
18 NON-SMALL CELL LUNG CANCER STAGE IV 14 0.0384
19 DERMATITIS ACNEIFORM 232 0.0381
20 TRICHIASIS 12 0.0377
21 ANTIBIOTIC RESISTANT STAPHYLOCOCCUS TEST POSITIVE 4 0.0336
22 GROWTH OF EYELASHES 26 0.0328
23 SCLERODERMA-LIKE REACTION 5 0.0316
24 PARONYCHIA 134 0.0305
25 METASTASES TO NECK 8 0.0287
26 NON-SMALL CELL LUNG CANCER 135 0.0282
27 LUNG SQUAMOUS CELL CARCINOMA STAGE UNSPECIFIED 5 0.0278
28 METASTASES TO THE MEDIASTINUM 11 0.0267
29 XERODERMA 7 0.0262
30 PLEURAL INFECTION 6 0.0258
31 LUNG ADENOCARCINOMA 77 0.0256
32 MALIGNANT PLEURAL EFFUSION 40 0.0237
33 LUNG CYST 8 0.0204
34 SMALL CELL CARCINOMA 7 0.0203
35 XEROSIS 25 0.0202
36 PYOGENIC GRANULOMA 9 0.0193
37 HEPATOBILIARY DISEASE 12 0.0192
38 CHOLANGITIS INFECTIVE 5 0.0188
39 DRUG RESISTANCE 477 0.0186
40 DUODENAL STENOSIS 9 0.0185
41 METASTASES TO MENINGES 42 0.0185
42 LUNG CANCER METASTATIC 51 0.0177
43 NON-SMALL CELL LUNG CANCER RECURRENT 5 0.0177
44 CORNEAL EPITHELIUM DEFECT 10 0.0172
45 DUODENAL OBSTRUCTION 5 0.0167
46 ANAEMIA MEGALOBLASTIC 7 0.0157
47 PANCREATIC CARCINOMA METASTATIC 44 0.0155
48 GASTROENTERITIS RADIATION 5 0.0152
49 METASTASES TO BREAST 5 0.0151
50 CENTRAL NERVOUS SYSTEM HAEMORRHAGE 7 0.0150
51 ECTROPION 5 0.0148
52 METASTASES TO PLEURA 15 0.0143
53 RADIATION OESOPHAGITIS 5 0.0131
54 LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT 8 0.0129
55 METASTASES TO STOMACH 5 0.0128
56 SKIN TOXICITY 72 0.0127
57 METASTASES TO KIDNEY 7 0.0127
58 MULTIPLE-DRUG RESISTANCE 39 0.0126
59 TUMOUR ASSOCIATED FEVER 5 0.0122
60 GASTROINTESTINAL TOXICITY 57 0.0119
61 MALIGNANT ASCITES 9 0.0117
62 GENE MUTATION 23 0.0116
63 SUPERIOR VENA CAVA SYNDROME 7 0.0116
64 LYMPHANGIOSIS CARCINOMATOSA 12 0.0115
65 CARBOHYDRATE ANTIGEN 19-9 INCREASED 6 0.0113
66 VASOGENIC CEREBRAL OEDEMA 8 0.0111
67 MEIBOMIAN GLAND DYSFUNCTION 5 0.0110
68 PNEUMOPERITONEUM 20 0.0108
69 PULMONARY VASCULAR DISORDER 5 0.0106
70 SMALL CELL LUNG CANCER 16 0.0106
71 NAIL BED BLEEDING 6 0.0105
72 RADIATION NECROSIS 6 0.0105
73 RADIATION PNEUMONITIS 22 0.0103
74 METASTASES TO CENTRAL NERVOUS SYSTEM 131 0.0101
75 METASTASES TO SPINE 33 0.0098
76 METASTATIC SQUAMOUS CELL CARCINOMA 5 0.0098
77 RASH PUSTULAR 71 0.0097
78 CORNEAL PERFORATION 6 0.0095
79 METASTASES TO PELVIS 6 0.0095
80 ADENOCARCINOMA 21 0.0094
81 METASTASIS 66 0.0092
82 BRONCHOSTENOSIS 5 0.0091
83 COLON ADENOMA 9 0.0091
84 ULCERATIVE KERATITIS 25 0.0091
85 ONYCHALGIA 9 0.0090
86 PNEUMOTHORAX SPONTANEOUS 6 0.0088
87 PNEUMATOSIS INTESTINALIS 25 0.0088
88 MALIGNANT NEOPLASM PROGRESSION 892 0.0087
89 METASTASES TO ADRENALS 8 0.0087
90 ANASTOMOTIC LEAK 6 0.0086
91 HYDROTHORAX 7 0.0084
92 HAEMATOTOXICITY 80 0.0084
93 BILE DUCT STENOSIS 10 0.0083
94 PNEUMOCYSTIS JIROVECI PNEUMONIA 18 0.0081
95 PSOAS ABSCESS 5 0.0080
96 PLEURAL DISORDER 5 0.0080
97 AORTIC THROMBOSIS 9 0.0078
98 NASAL CRUSTING 5 0.0077
99 BRONCHIAL CARCINOMA 6 0.0076
100 HISTOPLASMOSIS DISSEMINATED 12 0.0076
101 NASAL ULCER 12 0.0075
102 FAILURE TO THRIVE 39 0.0075
103 GASTROINTESTINAL PERFORATION 31 0.0074
104 PARANEOPLASTIC SYNDROME 5 0.0074
105 ACNE PUSTULAR 6 0.0073
106 METASTASES TO LUNG 84 0.0073
107 EMBOLISM 60 0.0072
108 METASTASES TO PERITONEUM 18 0.0071
109 OBSTRUCTION GASTRIC 9 0.0070
110 RADIATION SKIN INJURY 8 0.0069
111 PLEURAL FIBROSIS 7 0.0069
112 BLOOD ALKALINE PHOSPHATASE ABNORMAL 6 0.0067
113 PERFORMANCE STATUS DECREASED 31 0.0066
114 BILIARY TRACT INFECTION 4 0.0064
115 BILE DUCT OBSTRUCTION 12 0.0063
116 SUPERINFECTION BACTERIAL 5 0.0063
117 CHOLANGITIS 39 0.0063
118 NAIL INFECTION 9 0.0063
119 CARCINOEMBRYONIC ANTIGEN INCREASED 12 0.0062
120 METASTATIC NEOPLASM 26 0.0060
121 OESOPHAGEAL VARICES HAEMORRHAGE 13 0.0060
122 ASPARTATE AMINOTRANSFERASE ABNORMAL 9 0.0059
123 HEPATIC CANCER METASTATIC 5 0.0058
124 HEPATIC HAEMORRHAGE 5 0.0058
125 INTESTINAL ULCER 9 0.0057
126 METASTASES TO BONE 90 0.0055
127 KLEBSIELLA SEPSIS 6 0.0053
128 TUMOUR PAIN 7 0.0053
129 PROTEINURIA 101 0.0053
130 PNEUMONIA CRYPTOCOCCAL 5 0.0053
131 BREATH SOUNDS ABNORMAL 26 0.0053
132 BLEPHARITIS 21 0.0052
133 METASTASES TO LIVER 92 0.0052
134 THERAPY PARTIAL RESPONDER 80 0.0051
135 BONE MARROW TOXICITY 6 0.0051
136 CARDIAC DEATH 6 0.0050
137 CEREBRAL ISCHAEMIA 25 0.0049
138 PAPILLOMA VIRAL INFECTION 8 0.0048
139 SEBORRHOEIC DERMATITIS 8 0.0048
140 DISEASE PROGRESSION 572 0.0048
141 PLEURITIC PAIN 13 0.0047
142 BLOOD BILIRUBIN ABNORMAL 6 0.0047
143 LUNG NEOPLASM 20 0.0047
144 HYPOALBUMINAEMIA 36 0.0046
145 VENOUS THROMBOSIS 18 0.0046
146 ORAL INTAKE REDUCED 11 0.0045
147 ABDOMINAL SEPSIS 4 0.0045
148 LYMPHOPENIA 64 0.0045
149 ONYCHOCLASIS 31 0.0045
150 OESOPHAGITIS 49 0.0045
151 SMALL INTESTINAL HAEMORRHAGE 9 0.0045
152 PNEUMOMEDIASTINUM 8 0.0044
153 PNEUMOTHORAX 70 0.0044
154 PLEURAL EFFUSION 267 0.0044
155 LEUKOCYTOCLASTIC VASCULITIS 7 0.0043
156 CACHEXIA 22 0.0043
157 ALANINE AMINOTRANSFERASE ABNORMAL 9 0.0043
158 HAEMOPTYSIS 119 0.0043
159 RECTAL ULCER 5 0.0043
160 DEATH 3661 0.0042
161 PNEUMONITIS 115 0.0042
162 LUNG NEOPLASM MALIGNANT 172 0.0042
163 ESCHERICHIA TEST POSITIVE 5 0.0042
164 EXFOLIATIVE RASH 11 0.0042
165 AMYLASE INCREASED 15 0.0041
166 MUCOSAL INFLAMMATION 105 0.0040
167 NEOPLASM 46 0.0040
168 HYPERBILIRUBINAEMIA 41 0.0040
169 OESOPHAGEAL ULCER 15 0.0039
170 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 9 0.0039
171 METASTASES TO LYMPH NODES 26 0.0038
172 HYPERSENSITIVITY VASCULITIS 10 0.0038
173 LEFT VENTRICULAR DYSFUNCTION 25 0.0037
174 RECURRENT CANCER 15 0.0037
175 LYMPHADENOPATHY MEDIASTINAL 7 0.0037
176 CORNEAL DISORDER 8 0.0036
177 HOSPICE CARE 36 0.0036
178 VARICES OESOPHAGEAL 11 0.0036
179 HEPATIC MASS 7 0.0036
180 MOTION SICKNESS 7 0.0036
181 LARGE INTESTINAL OBSTRUCTION 8 0.0036
182 PERIPHERAL MOTOR NEUROPATHY 5 0.0036
183 HYPOMAGNESAEMIA 49 0.0035
184 SQUAMOUS CELL CARCINOMA 33 0.0035
185 BLOOD CHLORIDE DECREASED 9 0.0035
186 HAIR GROWTH ABNORMAL 24 0.0035
187 ACUTE PRERENAL FAILURE 4 0.0035
188 GASTRITIS EROSIVE 16 0.0034
189 BILIRUBIN CONJUGATED INCREASED 8 0.0034
190 JAUNDICE CHOLESTATIC 12 0.0034
191 PURPURA 30 0.0034
192 INGROWING NAIL 8 0.0034
193 INTERNATIONAL NORMALISED RATIO FLUCTUATION 7 0.0034
194 NEOPLASM PROGRESSION 117 0.0034
195 NAIL DISORDER 29 0.0033
196 HEPATIC NEOPLASM MALIGNANT 7 0.0033
197 INTERSTITIAL LUNG DISEASE 160 0.0033
198 LEUKOENCEPHALOPATHY 12 0.0032
199 ATELECTASIS 31 0.0032
200 HEPATOTOXICITY 71 0.0032
201 NEOPLASM MALIGNANT 212 0.0032
202 LUNG INFILTRATION 28 0.0032
203 LARGE INTESTINE PERFORATION 22 0.0032
204 KERATOPATHY 5 0.0032
205 GASTROINTESTINAL ULCER 7 0.0032
206 LUNG INFECTION 49 0.0032
207 ASCITES 91 0.0031
208 RASH 1323 0.0030
209 PLEURISY 18 0.0030
210 PEPTIC ULCER 10 0.0030
211 VENA CAVA THROMBOSIS 5 0.0030
212 HEPATIC LESION 13 0.0030
213 BLOOD CULTURE POSITIVE 9 0.0030
214 BLOOD BILIRUBIN INCREASED 81 0.0030
215 OSTEOLYSIS 6 0.0029
216 PORTAL HYPERTENSION 9 0.0029
217 BLOOD ALBUMIN DECREASED 23 0.0029
218 BILIARY TRACT DISORDER 4 0.0029
219 SUBILEUS 6 0.0029
220 INTESTINAL PERFORATION 32 0.0028
221 DEHYDRATION 380 0.0028
222 SMALL INTESTINAL OBSTRUCTION 35 0.0028
223 HYPOKALAEMIA 129 0.0028
224 VOCAL CORD PARALYSIS 5 0.0028
225 DIVERTICULUM INTESTINAL 12 0.0027
226 BILIARY DILATATION 4 0.0027
227 LOBAR PNEUMONIA 5 0.0027
228 PARESIS 6 0.0027
229 PULMONARY HAEMORRHAGE 21 0.0027
230 WOUND DEHISCENCE 9 0.0027
231 CLOSTRIDIAL INFECTION 9 0.0027
232 NEOPLASM RECURRENCE 9 0.0027
233 SUDDEN DEATH 28 0.0026
234 ANAEMIA 500 0.0026
235 HAIR TEXTURE ABNORMAL 35 0.0026
236 ARTERIAL THROMBOSIS 5 0.0026
237 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 60 0.0026
238 HYPOVOLAEMIA 15 0.0026
239 HYPOGEUSIA 5 0.0025
240 DRUG ERUPTION 45 0.0025
241 HYPONATRAEMIA 143 0.0025
242 PUSTULE 6 0.0025
243 SKIN ULCER 65 0.0025
244 LUNG CONSOLIDATION 7 0.0025
245 HYPOXIA 88 0.0025
246 CANDIDIASIS 10 0.0025
247 GASTROINTESTINAL OBSTRUCTION 6 0.0025
248 SKIN EROSION 8 0.0025
249 MUCOSAL DRYNESS 5 0.0025
250 CONJUNCTIVITIS 46 0.0025
251 PULMONARY EMBOLISM 235 0.0025
252 RESPIRATORY FAILURE 180 0.0025
253 HYPOPHOSPHATAEMIA 18 0.0024
254 HAEMOTHORAX 7 0.0024
255 DUODENAL ULCER 17 0.0024
256 STOMATITIS 146 0.0024
257 PROTEIN URINE PRESENT 12 0.0024
258 PULMONARY PAIN 7 0.0024
259 DIVERTICULUM 17 0.0024
260 PROTEIN TOTAL DECREASED 9 0.0024
261 HYDROCEPHALUS 13 0.0024
262 URINARY BLADDER HAEMORRHAGE 5 0.0024
263 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 8 0.0024
264 BUNDLE BRANCH BLOCK LEFT 10 0.0024
265 ASPARTATE AMINOTRANSFERASE INCREASED 124 0.0023
266 METABOLIC ENCEPHALOPATHY 7 0.0023
267 KERATITIS 7 0.0023
268 SKIN FISSURES 45 0.0023
269 DERMATITIS 48 0.0023
270 NAIL DISCOLOURATION 9 0.0023
271 HENOCH-SCHONLEIN PURPURA 5 0.0023
272 APHAGIA 11 0.0023
273 DUODENITIS 7 0.0023
274 LEUKOPENIA 114 0.0023
275 PULMONARY TOXICITY 16 0.0023
276 THROMBOTIC MICROANGIOPATHY 22 0.0023
277 ILEUS 28 0.0023
278 PERIPHERAL SENSORY NEUROPATHY 13 0.0022
279 IRIDOCYCLITIS 7 0.0022
280 NON-CARDIAC CHEST PAIN 7 0.0022
281 GASTRIC ULCER 42 0.0022
282 DECREASED APPETITE 511 0.0022
283 SPINAL COMPRESSION FRACTURE 18 0.0022
284 BLOOD ALKALINE PHOSPHATASE INCREASED 54 0.0022
285 PORTAL VEIN THROMBOSIS 7 0.0022
286 MENTAL STATUS CHANGES 60 0.0022
287 TRICHORRHEXIS 6 0.0021
288 BACTERIAL SEPSIS 7 0.0021
289 PULMONARY MASS 32 0.0021
290 ACUTE RESPIRATORY FAILURE 41 0.0021
291 DISSEMINATED INTRAVASCULAR COAGULATION 30 0.0021
292 PERICARDIAL EFFUSION 49 0.0021
293 HYPOCALCAEMIA 40 0.0021
294 CARDIAC FAILURE CHRONIC 9 0.0021
295 TUMOUR HAEMORRHAGE 6 0.0021
296 DIARRHOEA 1341 0.0021
297 SKIN DISORDER 69 0.0021
298 BRAIN NEOPLASM 19 0.0021
299 BONE MARROW FAILURE 41 0.0020
300 ABDOMINAL TENDERNESS 10 0.0020
301 ODYNOPHAGIA 12 0.0020
302 HYDRONEPHROSIS 15 0.0020
303 AZOTAEMIA 8 0.0020
304 THYROIDITIS 6 0.0020
305 ORGAN FAILURE 8 0.0020
306 GASTRIC ULCER HAEMORRHAGE 11 0.0020
307 NEUTROPENIA 268 0.0020
308 PULMONARY ALVEOLAR HAEMORRHAGE 11 0.0020
309 ISCHAEMIA 9 0.0020
310 CANCER PAIN 5 0.0020
311 HYPOPHAGIA 50 0.0020
312 AORTIC ARTERIOSCLEROSIS 5 0.0019
313 MASS 27 0.0019
314 ALANINE AMINOTRANSFERASE INCREASED 118 0.0019
315 FLANK PAIN 18 0.0019
316 CUTANEOUS VASCULITIS 7 0.0019
317 THROMBOCYTOPENIA 211 0.0019
318 ACUTE RESPIRATORY DISTRESS SYNDROME 33 0.0019
319 HAEMOGLOBIN ABNORMAL 12 0.0019
320 DECUBITUS ULCER 15 0.0018
321 MELANOCYTIC NAEVUS 8 0.0018
322 ONYCHOMYCOSIS 8 0.0018
323 FOLLICULITIS 19 0.0018
324 SPINAL CORD COMPRESSION 7 0.0018
325 ILEUS PARALYTIC 8 0.0018
326 BRAIN NEOPLASM MALIGNANT 8 0.0018
327 ACNE 134 0.0018
328 OESOPHAGEAL STENOSIS 5 0.0018
329 BLOOD DISORDER 14 0.0017
330 SKIN HYPERPIGMENTATION 15 0.0017
331 GASTRIC HAEMORRHAGE 20 0.0017
332 LYMPHOEDEMA 12 0.0017
333 ESCHERICHIA SEPSIS 5 0.0017
334 AORTIC STENOSIS 6 0.0017
335 HEPATITIS 44 0.0017
336 CEREBRAL INFARCTION 42 0.0017
337 SKIN REACTION 24 0.0017
338 THROMBOTIC THROMBOCYTOPENIC PURPURA 6 0.0017
339 FEBRILE NEUTROPENIA 112 0.0017
340 HEPATIC FUNCTION ABNORMAL 63 0.0017
341 CONJUNCTIVAL HYPERAEMIA 6 0.0017
342 CONGESTIVE CARDIOMYOPATHY 7 0.0017
343 EPISTAXIS 125 0.0017
344 PYODERMA GANGRENOSUM 6 0.0017
345 TRANSAMINASES INCREASED 37 0.0017
346 CHEILITIS 9 0.0017
347 RENAL FAILURE ACUTE 70 0.0016
348 PNEUMONIA ASPIRATION 41 0.0016
349 HAEMORRHOIDAL HAEMORRHAGE 8 0.0016
350 THROMBOCYTOSIS 6 0.0016
351 EYE DISCHARGE 17 0.0016
352 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 4 0.0016
353 DRUG TOXICITY 22 0.0016
354 CARDIAC DYSFUNCTION 6 0.0016
355 FLUID INTAKE REDUCED 8 0.0016
356 PANCREATIC CARCINOMA 46 0.0016
357 DEEP VEIN THROMBOSIS 103 0.0016
358 ULCER 25 0.0016
359 MULTI-ORGAN FAILURE 27 0.0016
360 GENERAL PHYSICAL HEALTH DETERIORATION 180 0.0016
361 SINUS TACHYCARDIA 22 0.0015
362 LIVER ABSCESS 5 0.0015
363 REFUSAL OF TREATMENT BY PATIENT 10 0.0015
364 MALNUTRITION 17 0.0015
365 MOUTH ULCERATION 32 0.0015
366 HYPERGLYCAEMIA 55 0.0015
367 MOUTH HAEMORRHAGE 11 0.0015
368 HEPATIC ENCEPHALOPATHY 14 0.0015
369 LEUKOCYTOSIS 27 0.0015
370 UPPER GASTROINTESTINAL HAEMORRHAGE 25 0.0015
371 NEUROTOXICITY 26 0.0015
372 SUPRAVENTRICULAR EXTRASYSTOLES 5 0.0015
373 CARDIAC TAMPONADE 7 0.0015
374 PERIPHERAL ISCHAEMIA 6 0.0015
375 HICCUPS 12 0.0015
376 BRONCHOPNEUMONIA 5 0.0015
377 HYPERCALCAEMIA 18 0.0015
378 PIGMENTATION DISORDER 9 0.0015
379 FAECAL INCONTINENCE 7 0.0015
380 VIITH NERVE PARALYSIS 5 0.0014
381 RASH VESICULAR 7 0.0014
382 DRY SKIN 193 0.0014
383 NECROSIS 8 0.0014
384 ONYCHOMADESIS 6 0.0014
385 CHOLECYSTITIS 17 0.0014
386 EAR PRURITUS 5 0.0014
387 MUSCULOSKELETAL CHEST PAIN 22 0.0014
388 HAEMATEMESIS 36 0.0014
389 LYMPHOCYTE COUNT DECREASED 25 0.0014
390 ORGANISING PNEUMONIA 7 0.0014
391 NEUTROPHIL COUNT DECREASED 57 0.0014
392 ERYSIPELAS 7 0.0014
393 SKIN ATROPHY 8 0.0014
394 PULMONARY OEDEMA 62 0.0014
395 KLEBSIELLA INFECTION 7 0.0014
396 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 7 0.0014
397 LACERATION 13 0.0014
398 STAPHYLOCOCCAL BACTERAEMIA 6 0.0014
399 FRACTURE 26 0.0014
400 URINE OUTPUT DECREASED 12 0.0014
401 VENTRICULAR ARRHYTHMIA 5 0.0014
402 STAPHYLOCOCCAL INFECTION 45 0.0014
403 HAEMOGLOBIN DECREASED 140 0.0014
404 RASH MACULO-PAPULAR 30 0.0013
405 BRAIN OEDEMA 17 0.0013
406 CARDIOTOXICITY 12 0.0013
407 PROTHROMBIN TIME PROLONGED 8 0.0013
408 HAIR DISORDER 11 0.0013
409 INTERNATIONAL NORMALISED RATIO INCREASED 38 0.0013
410 ULCER HAEMORRHAGE 9 0.0013
411 ACUTE CORONARY SYNDROME 11 0.0013
412 OEDEMA 72 0.0013
413 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 5 0.0013
414 COMPRESSION FRACTURE 7 0.0013
415 LIPASE INCREASED 10 0.0013
416 PNEUMONIA 421 0.0013
417 LARGE INTESTINE POLYP 9 0.0013
418 HEMIPARESIS 22 0.0013
419 THERAPEUTIC PRODUCT INEFFECTIVE 5 0.0013
420 FACIAL PARALYSIS 11 0.0013
421 EMPHYSEMA 13 0.0013
422 ERYTHEMA MULTIFORME 12 0.0013
423 CARDIOPULMONARY FAILURE 5 0.0013
424 PAPULE 9 0.0013
425 DYSPHAGIA 120 0.0013
426 HEPATIC FAILURE 38 0.0013
427 GASTROINTESTINAL HAEMORRHAGE 105 0.0013
428 OBSTRUCTION 5 0.0013
429 ENTERITIS 8 0.0012
430 DYSPNOEA EXERTIONAL 47 0.0012
431 DISEASE RECURRENCE 59 0.0012
432 ASTHENIA 462 0.0012
433 SEPSIS 137 0.0012
434 CYTOPENIA 15 0.0012
435 VOMITING 576 0.0012
436 DEMYELINATION 5 0.0012
437 ORAL CANDIDIASIS 16 0.0012
438 LIGAMENT SPRAIN 12 0.0012
439 HAEMATOCRIT DECREASED 24 0.0012
440 APPETITE DISORDER 8 0.0012
441 ELECTROLYTE IMBALANCE 14 0.0012
442 PANCREATITIS ACUTE 27 0.0012
443 DERMATITIS EXFOLIATIVE 6 0.0012
444 INTESTINAL OBSTRUCTION 45 0.0012
445 APHASIA 36 0.0012
446 ASPIRATION 13 0.0012
447 COLITIS ISCHAEMIC 8 0.0012
448 FEEDING DISORDER 24 0.0012
449 HYPERPYREXIA 5 0.0012
450 PURULENT DISCHARGE 5 0.0012
451 BLOOD SODIUM DECREASED 22 0.0012
452 HYPERTENSION 247 0.0012
453 BLOOD MAGNESIUM DECREASED 10 0.0012
454 FISTULA 13 0.0012
455 BLOOD CALCIUM DECREASED 13 0.0012
456 EYE DISORDER 38 0.0012
457 EYE INFECTION 13 0.0012
458 MONOPLEGIA 5 0.0011
459 NO THERAPEUTIC RESPONSE 14 0.0011
460 HAEMORRHAGIC ANAEMIA 5 0.0011
461 CLOSTRIDIUM DIFFICILE COLITIS 12 0.0011
462 ABDOMINAL PAIN 262 0.0011
463 GASTROINTESTINAL MOTILITY DISORDER 6 0.0011
464 NEUTROPENIC SEPSIS 8 0.0011
465 GASTRITIS 29 0.0011
466 PULMONARY THROMBOSIS 12 0.0011
467 OSTEONECROSIS OF JAW 27 0.0011
468 DEAFNESS UNILATERAL 6 0.0011
469 GAMMA-GLUTAMYLTRANSFERASE INCREASED 24 0.0011
470 CARDIOMYOPATHY 16 0.0011
471 LOCALISED OEDEMA 5 0.0011
472 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 11 0.0011
473 SKIN INFECTION 12 0.0011
474 NEPHROPATHY TOXIC 12 0.0011
475 OEDEMA PERIPHERAL 130 0.0011
476 PLATELET COUNT DECREASED 113 0.0011
477 SKIN LESION 29 0.0011
478 TENDERNESS 11 0.0011
479 SCAB 12 0.0011
480 VIRAL UPPER RESPIRATORY TRACT INFECTION 5 0.0011
481 CARDIAC FAILURE ACUTE 7 0.0010
482 DEVICE RELATED INFECTION 16 0.0010
483 EATING DISORDER 22 0.0010
484 OFF LABEL USE 904 0.0010
485 SPINAL OSTEOARTHRITIS 9 0.0010
486 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 53 0.0010
487 BLOOD UREA INCREASED 17 0.0010
488 CONSTIPATION 221 0.0010
489 ATAXIA 12 0.0010
490 ANOREXIA 13 0.0010
491 FACIAL PAIN 9 0.0010
492 RENAL CYST 8 0.0010
493 AUTOIMMUNE HEPATITIS 7 0.0010
494 HYPERNATRAEMIA 5 0.0010
495 LIVER FUNCTION TEST ABNORMAL 29 0.0010
496 ARTERIOSPASM CORONARY 4 0.0010
497 CARDIAC FAILURE 80 0.0010
498 WEIGHT DECREASED 278 0.0010
499 RHINITIS 8 0.0010
500 PYREXIA 341 0.0010
501 PATHOLOGICAL FRACTURE 5 0.0010
502 ASPHYXIA 8 0.0010
503 UROSEPSIS 9 0.0010
504 FEMORAL NECK FRACTURE 5 0.0010
505 INFECTION 141 0.0010
506 HYPERAESTHESIA 8 0.0010
507 HYPERKALAEMIA 34 0.0010
508 NEUROPATHY PERIPHERAL 92 0.0010
509 DRUG LEVEL INCREASED 16 0.0010
510 SEPTIC SHOCK 42 0.0010
511 DIARRHOEA HAEMORRHAGIC 9 0.0010
512 DRY EYE 48 0.0010
513 ARTERIOSCLEROSIS 9 0.0010
514 DRUG INTERACTION 150 0.0009
515 JAUNDICE 25 0.0009
516 HERPES SIMPLEX 6 0.0009
517 HAEMORRHOIDS 18 0.0009
518 FAECES DISCOLOURED 20 0.0009
519 FATIGUE 718 0.0009
520 HEPATOCELLULAR CARCINOMA 7 0.0009
521 PARALYSIS 13 0.0009
522 INTESTINAL ISCHAEMIA 5 0.0009
523 LYMPHADENOPATHY 32 0.0009
524 BLOOD CREATININE INCREASED 59 0.0009
525 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 7 0.0009
526 SKIN EXFOLIATION 76 0.0009
527 MENINGITIS 6 0.0009
528 LUNG DISORDER 44 0.0009
529 THROMBOSIS 72 0.0009
530 PANCYTOPENIA 50 0.0009
531 TOXIC SKIN ERUPTION 9 0.0009
532 TORSADE DE POINTES 7 0.0009
533 HAEMATOMA 23 0.0009
534 BONE PAIN 52 0.0009
535 FURUNCLE 7 0.0009
536 CHOLECYSTITIS ACUTE 5 0.0009
537 AGEUSIA 22 0.0009
538 TRICUSPID VALVE INCOMPETENCE 7 0.0009
539 NEUTROPHIL COUNT INCREASED 9 0.0009
540 MYOCARDIAL ISCHAEMIA 10 0.0009
541 NAUSEA 694 0.0009
542 ECCHYMOSIS 6 0.0009
543 MOVEMENT DISORDER 28 0.0009
544 HAEMORRHAGE 91 0.0009
545 RESPIRATORY DISTRESS 24 0.0009
546 ENTEROCOLITIS 5 0.0009
547 EYE PRURITUS 29 0.0009
548 MALAISE 378 0.0009
549 METABOLIC DISORDER 5 0.0009
550 WHITE BLOOD CELL COUNT INCREASED 33 0.0009
551 HYPOACUSIS 37 0.0009
552 DYSPNOEA 486 0.0009
553 COUGH 240 0.0009
554 CELLULITIS 43 0.0009
555 INCORRECT DOSE ADMINISTERED 194 0.0008
556 RASH GENERALISED 22 0.0008
557 GENERALISED TONIC-CLONIC SEIZURE 14 0.0008
558 RENAL FAILURE 112 0.0008
559 BEDRIDDEN 11 0.0008
560 HEARING IMPAIRED 5 0.0008
561 BLOOD POTASSIUM DECREASED 25 0.0008
562 ALOPECIA 163 0.0008
563 FOETAL GROWTH RESTRICTION 5 0.0008
564 GASTROENTERITIS 12 0.0008
565 UTERINE LEIOMYOMA 6 0.0008
566 MELAENA 18 0.0008
567 COLITIS 31 0.0008
568 PSEUDOMONAS INFECTION 7 0.0008
569 CARDIOMEGALY 10 0.0008
570 LARYNGEAL OEDEMA 5 0.0008
571 CONFUSIONAL STATE 131 0.0008
572 TACHYPNOEA 11 0.0008
573 NERVOUS SYSTEM DISORDER 25 0.0008
574 CENTRAL NERVOUS SYSTEM LESION 11 0.0008
575 PNEUMOCYSTIS JIROVECII PNEUMONIA 8 0.0008
576 MUSCLE ATROPHY 10 0.0008
577 ACIDOSIS 6 0.0008
578 ISCHAEMIC STROKE 14 0.0008
579 DYSPEPSIA 77 0.0008
580 MUSCULOSKELETAL PAIN 41 0.0008
581 PULMONARY FIBROSIS 15 0.0008
582 DEVICE OCCLUSION 11 0.0008
583 ANAL INCONTINENCE 7 0.0008
584 MADAROSIS 9 0.0008
585 PRODUCTIVE COUGH 37 0.0008
586 ATRIAL FIBRILLATION 75 0.0008
587 HEPATITIS ACUTE 5 0.0008
588 SPINAL PAIN 9 0.0008
589 DRUG INTOLERANCE 74 0.0008
590 BRADYPHRENIA 5 0.0008
591 PNEUMONIA BACTERIAL 7 0.0008
592 BLOOD LACTIC ACID INCREASED 4 0.0008
593 IRON DEFICIENCY ANAEMIA 7 0.0008
594 BLOOD LACTATE DEHYDROGENASE INCREASED 12 0.0008
595 GINGIVAL PAIN 6 0.0008
596 FUNGAL INFECTION 25 0.0007
597 LETHARGY 43 0.0007
598 HIP FRACTURE 24 0.0007
599 BLOOD POTASSIUM INCREASED 12 0.0007
600 IMMUNODEFICIENCY 11 0.0007
601 GENERAL PHYSICAL CONDITION ABNORMAL 5 0.0007
602 UNRESPONSIVE TO STIMULI 19 0.0007
603 CONVULSION 42 0.0007
604 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 7 0.0007
605 LIVER INJURY 18 0.0007
606 GINGIVAL BLEEDING 10 0.0007
607 ESCHERICHIA INFECTION 6 0.0007
608 LACRIMATION INCREASED 22 0.0007
609 HYPOTENSION 146 0.0007
610 GASTROINTESTINAL PAIN 8 0.0007
611 DEAFNESS 19 0.0007
612 DENTAL CARIES 8 0.0007
613 DIZZINESS POSTURAL 7 0.0007
614 VENTRICULAR FIBRILLATION 8 0.0007
615 HYPERTRANSAMINASAEMIA 5 0.0007
616 ORAL PAIN 16 0.0007
617 ANGIOPATHY 4 0.0007
618 DYSGEUSIA 53 0.0007
619 HEPATOMEGALY 7 0.0007
620 VITREOUS FLOATERS 7 0.0007
621 MITRAL VALVE INCOMPETENCE 8 0.0007
622 HAND FRACTURE 5 0.0007
623 THERMAL BURN 5 0.0007
624 CIRCULATORY COLLAPSE 12 0.0007
625 HEPATIC ENZYME INCREASED 48 0.0007
626 WHITE BLOOD CELL COUNT DECREASED 76 0.0007
627 SUBDURAL HAEMATOMA 10 0.0007
628 MYOCARDITIS 8 0.0007
629 HIATUS HERNIA 9 0.0007
630 EYE IRRITATION 40 0.0007
631 RESPIRATORY TRACT INFECTION 18 0.0007
632 DERMATITIS BULLOUS 5 0.0007
633 PLATELET COUNT INCREASED 9 0.0007
634 ABDOMINAL DISTENSION 72 0.0007
635 EYELID OEDEMA 8 0.0007
636 DRUG LEVEL DECREASED 7 0.0007
637 TACHYCARDIA 61 0.0007
638 BODY TEMPERATURE INCREASED 14 0.0007
639 NIGHT SWEATS 22 0.0007
640 ORAL DISORDER 5 0.0007
641 TUMOUR LYSIS SYNDROME 6 0.0007
642 IMMUNOSUPPRESSION 6 0.0007
643 ACUTE MYOCARDIAL INFARCTION 20 0.0007
644 LOWER LIMB FRACTURE 13 0.0007
645 LOWER GASTROINTESTINAL HAEMORRHAGE 5 0.0007
646 BACTERAEMIA 8 0.0007
647 PULMONARY HYPERTENSION 14 0.0007
648 HAEMATURIA 23 0.0007
649 PETECHIAE 7 0.0007
650 SUNBURN 5 0.0007
651 MYOSITIS 6 0.0007
652 VENTRICULAR TACHYCARDIA 11 0.0007
653 TREATMENT FAILURE 55 0.0007
654 HYPOAESTHESIA ORAL 10 0.0007
655 VISUAL ACUITY REDUCED 22 0.0007
656 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 47 0.0007
657 ILL-DEFINED DISORDER 40 0.0007
658 GASTROOESOPHAGEAL REFLUX DISEASE 53 0.0007
659 AORTIC ANEURYSM 5 0.0007
660 TROPONIN INCREASED 5 0.0007
661 LIVER DISORDER 29 0.0007
662 RETINAL DETACHMENT 6 0.0007
663 RENAL FAILURE CHRONIC 5 0.0006
664 SYNCOPE 65 0.0006
665 DIVERTICULITIS 18 0.0006
666 FEELING COLD 18 0.0006
667 GENERALISED OEDEMA 8 0.0006
668 BRONCHOPULMONARY ASPERGILLOSIS 5 0.0006
669 PANCREATITIS 34 0.0006
670 PELVIC FRACTURE 5 0.0006
671 CHOLELITHIASIS 21 0.0006
672 HEPATOCELLULAR INJURY 9 0.0006
673 MUSCULAR WEAKNESS 72 0.0006
674 RIB FRACTURE 13 0.0006
675 LOW BIRTH WEIGHT BABY 5 0.0006
676 EYE INFLAMMATION 6 0.0006
677 PERITONITIS 13 0.0006
678 CARDIOGENIC SHOCK 9 0.0006
679 BACK PAIN 145 0.0006
680 BLISTER 35 0.0006
681 TRANSIENT ISCHAEMIC ATTACK 21 0.0006
682 HYPERTHYROIDISM 9 0.0006
683 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 44 0.0006
684 ANGINA UNSTABLE 4 0.0006
685 NODULE 8 0.0006
686 GASTRIC DISORDER 21 0.0006
687 RENAL TUBULAR NECROSIS 6 0.0006
688 IMPAIRED HEALING 20 0.0006
689 SKIN HAEMORRHAGE 9 0.0006
690 DEPRESSED LEVEL OF CONSCIOUSNESS 24 0.0006
691 CHEST PAIN 112 0.0006
692 DYSPHONIA 35 0.0006
693 DYSURIA 22 0.0006
694 BLOOD COUNT ABNORMAL 9 0.0006
695 SINUS CONGESTION 8 0.0006
696 BLOOD CREATINE PHOSPHOKINASE INCREASED 17 0.0006
697 UVEITIS 8 0.0006
698 RASH ERYTHEMATOUS 28 0.0006
699 UPPER RESPIRATORY TRACT INFECTION 27 0.0006
700 MYELOSUPPRESSION 21 0.0006
701 TEMPERATURE INTOLERANCE 6 0.0006
702 MYOPATHY 5 0.0006
703 PYELONEPHRITIS 5 0.0006
704 ORTHOSTATIC HYPOTENSION 10 0.0006
705 DISCOMFORT 35 0.0006
706 CHOLESTASIS 11 0.0006
707 BLOOD CALCIUM INCREASED 5 0.0006
708 ENCEPHALOPATHY 14 0.0006
709 CARDIAC ARREST 47 0.0006
710 SHOCK 13 0.0006
711 HYPOTHYROIDISM 18 0.0006
712 RENAL IMPAIRMENT 47 0.0006
713 CEREBRAL HAEMORRHAGE 20 0.0006
714 DECREASED ACTIVITY 6 0.0006
715 SPEECH DISORDER 29 0.0006
716 DRUG EFFECT INCOMPLETE 20 0.0006
717 FALL 183 0.0005
718 ACUTE KIDNEY INJURY 84 0.0005
719 BONE DISORDER 10 0.0005
720 DELIRIUM 19 0.0005
721 COMA 26 0.0005
722 PHOTOSENSITIVITY REACTION 9 0.0005
723 INCREASED TENDENCY TO BRUISE 5 0.0005
724 BLOOD THYROID STIMULATING HORMONE INCREASED 5 0.0005
725 CEREBROVASCULAR ACCIDENT 92 0.0005
726 URINARY INCONTINENCE 16 0.0005
727 BACTERIAL INFECTION 10 0.0005
728 RECTAL HAEMORRHAGE 23 0.0005
729 RESPIRATORY DISORDER 16 0.0005
730 PRESYNCOPE 13 0.0005
731 FACE OEDEMA 9 0.0005
732 URINARY TRACT INFECTION 91 0.0005
733 CANDIDA INFECTION 9 0.0005
734 HEPATIC CIRRHOSIS 10 0.0005
735 OSTEOPENIA 8 0.0005
736 CARDIO-RESPIRATORY ARREST 22 0.0005
737 RED BLOOD CELL COUNT DECREASED 15 0.0005
738 EYE HAEMORRHAGE 7 0.0005
739 EPILEPSY 16 0.0005
740 CARDIAC FAILURE CONGESTIVE 42 0.0005
741 SUPRAVENTRICULAR TACHYCARDIA 5 0.0005
742 PAIN OF SKIN 14 0.0005
743 SINUS BRADYCARDIA 5 0.0005
744 RASH PRURITIC 28 0.0005
745 ORAL HERPES 10 0.0005
746 CARDIOVASCULAR DISORDER 13 0.0005
747 VIRAL INFECTION 17 0.0005
748 EYE SWELLING 19 0.0005
749 DRUG-INDUCED LIVER INJURY 16 0.0005
750 PERIPHERAL COLDNESS 7 0.0005
751 GALLBLADDER DISORDER 9 0.0005
752 CATARACT 30 0.0005
753 APHONIA 7 0.0005
754 NEPHROLITHIASIS 23 0.0005
755 ABSCESS 8 0.0005
756 PAIN 308 0.0005
757 ATRIAL FLUTTER 4 0.0005
758 TINNITUS 23 0.0005
759 VISUAL IMPAIRMENT 62 0.0005
760 BRAIN INJURY 5 0.0005
761 TOOTHACHE 9 0.0005
762 PRURITUS 191 0.0005
763 FULL BLOOD COUNT DECREASED 10 0.0005
764 HYPOGLYCAEMIA 24 0.0005
765 NOCTURIA 6 0.0005
766 ABNORMAL FAECES 4 0.0005
767 HERPES ZOSTER 28 0.0005
768 CHILLS 57 0.0005
769 PHARYNGITIS 6 0.0005
770 HEPATIC STEATOSIS 9 0.0005
771 DYSARTHRIA 18 0.0005
772 WEIGHT FLUCTUATION 5 0.0005
773 FLATULENCE 27 0.0005
774 HAEMORRHAGE INTRACRANIAL 7 0.0005
775 INTENTIONAL PRODUCT USE ISSUE 41 0.0005
776 MUSCULOSKELETAL DISCOMFORT 8 0.0005
777 POOR QUALITY SLEEP 10 0.0005
778 PRURITUS GENERALISED 10 0.0005
779 DIPLOPIA 12 0.0005
780 AMNESIA 30 0.0005
781 PAIN IN JAW 13 0.0005
782 CLOSTRIDIUM DIFFICILE INFECTION 10 0.0005
783 GASTROINTESTINAL DISORDER 41 0.0005
784 LOCALISED INFECTION 11 0.0005
785 ANGINA PECTORIS 13 0.0005
786 HYPERSOMNIA 13 0.0005
787 OBSTRUCTIVE AIRWAYS DISORDER 5 0.0004
788 GAIT DISTURBANCE 86 0.0004
789 RHINORRHOEA 29 0.0004
790 RASH PAPULAR 10 0.0004
791 GOUT 8 0.0004
792 BRONCHITIS 33 0.0004
793 OCULAR DISCOMFORT 5 0.0004
794 ABASIA 11 0.0004
795 VISION BLURRED 61 0.0004
796 ARRHYTHMIA 21 0.0004
797 ABDOMINAL PAIN UPPER 91 0.0004
798 IMPAIRED GASTRIC EMPTYING 6 0.0004
799 ACUTE HEPATIC FAILURE 6 0.0004
800 METABOLIC ACIDOSIS 14 0.0004
801 INTERNAL HAEMORRHAGE 5 0.0004
802 RHABDOMYOLYSIS 18 0.0004
803 HOSPITALISATION 66 0.0004
804 NECK PAIN 24 0.0004
805 DEMENTIA 12 0.0004
806 VASCULITIS 5 0.0004
807 TUBULOINTERSTITIAL NEPHRITIS 8 0.0004
808 INFLAMMATION 22 0.0004
809 BLINDNESS UNILATERAL 6 0.0004
810 RETCHING 9 0.0004
811 WHEEZING 25 0.0004
812 CYTOMEGALOVIRUS INFECTION 7 0.0004
813 COAGULOPATHY 7 0.0004
814 FEMUR FRACTURE 13 0.0004
815 LIVER FUNCTION TEST INCREASED 9 0.0004
816 ALTERED STATE OF CONSCIOUSNESS 9 0.0004
817 MYELODYSPLASTIC SYNDROME 6 0.0004
818 HYPOKINESIA 6 0.0004
819 MYOCARDIAL INFARCTION 72 0.0004
820 INTERVERTEBRAL DISC PROTRUSION 9 0.0004
821 CYSTITIS 13 0.0004
822 ERYTHEMA 83 0.0004
823 CYST 5 0.0004
824 THERAPY NON-RESPONDER 18 0.0004
825 OCULAR HYPERAEMIA 19 0.0004
826 SPINAL FRACTURE 8 0.0004
827 CHROMATURIA 9 0.0004
828 SEIZURE 46 0.0004
829 LOWER RESPIRATORY TRACT INFECTION 18 0.0004
830 CONTUSION 38 0.0004
831 BLINDNESS 16 0.0004
832 SKIN DISCOLOURATION 18 0.0004
833 EYE PAIN 22 0.0004
834 HYPOAESTHESIA 58 0.0004
835 RENAL DISORDER 18 0.0004
836 PELVIC PAIN 7 0.0004
837 BASAL CELL CARCINOMA 6 0.0004
838 HAEMATOCHEZIA 21 0.0004
839 PULMONARY CONGESTION 5 0.0004
840 DISORIENTATION 15 0.0004
841 BODY HEIGHT DECREASED 4 0.0004
842 MALIGNANT MELANOMA 5 0.0004
843 BREAST CANCER METASTATIC 4 0.0004
844 CHEST DISCOMFORT 38 0.0004
845 BACK INJURY 4 0.0004
846 NASOPHARYNGITIS 67 0.0004
847 THERAPEUTIC RESPONSE DECREASED 22 0.0004
848 ERUCTATION 7 0.0004
849 ORAL DISCOMFORT 5 0.0004
850 DRY MOUTH 29 0.0004
851 PERICARDITIS 6 0.0004
852 SWELLING 33 0.0004
853 BLOOD PRESSURE ABNORMAL 7 0.0004
854 PARAESTHESIA 55 0.0003
855 FLUID OVERLOAD 5 0.0003
856 DEPRESSION 78 0.0003
857 CARDIAC DISORDER 32 0.0003
858 BALANCE DISORDER 29 0.0003
859 MYALGIA 57 0.0003
860 OSTEONECROSIS 11 0.0003
861 DIZZINESS 167 0.0003
862 ELECTROCARDIOGRAM QT PROLONGED 12 0.0003
863 GASTROENTERITIS VIRAL 6 0.0003
864 THERAPY CESSATION 17 0.0003
865 PALLOR 9 0.0003
866 CORONARY ARTERY DISEASE 10 0.0003
867 C-REACTIVE PROTEIN INCREASED 12 0.0003
868 URINARY RETENTION 11 0.0003
869 ABDOMINAL DISCOMFORT 55 0.0003
870 EMOTIONAL DISORDER 10 0.0003
871 OROPHARYNGEAL PAIN 30 0.0003
872 EJECTION FRACTION DECREASED 5 0.0003
873 ACUTE MYELOID LEUKAEMIA 5 0.0003
874 SWOLLEN TONGUE 10 0.0003
875 PHOTOPHOBIA 6 0.0003
876 CYANOSIS 5 0.0003
877 ABDOMINAL PAIN LOWER 8 0.0003
878 HEAD INJURY 10 0.0003
879 POLLAKIURIA 13 0.0003
880 SENSORY DISTURBANCE 5 0.0003
881 LACTIC ACIDOSIS 10 0.0003
882 EAR PAIN 6 0.0003
883 BACK DISORDER 5 0.0003
884 UPPER LIMB FRACTURE 6 0.0003
885 BLOOD PRESSURE DECREASED 20 0.0003
886 COGNITIVE DISORDER 14 0.0003
887 PAIN IN EXTREMITY 88 0.0003
888 PERIPHERAL SWELLING 46 0.0003
889 LIMB INJURY 8 0.0003
890 SCAR 5 0.0003
891 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 14 0.0003
892 TOXICITY TO VARIOUS AGENTS 49 0.0003
893 RESPIRATORY ARREST 8 0.0003
894 INSOMNIA 77 0.0003
895 NEURALGIA 7 0.0003
896 WOUND 8 0.0003
897 EOSINOPHILIA 5 0.0003
898 ANXIETY 81 0.0003
899 MULTIPLE ORGAN DYSFUNCTION SYNDROME 8 0.0003
900 VERTIGO 17 0.0003
901 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 8 0.0003
902 DRUG INEFFECTIVE 357 0.0003
903 TOOTH DISORDER 6 0.0003
904 RENAL INJURY 8 0.0003
905 GLOSSODYNIA 6 0.0003
906 LOSS OF CONSCIOUSNESS 34 0.0003
907 FOOT FRACTURE 5 0.0003
908 ARTHRALGIA 108 0.0003
909 HYPERSENSITIVITY 48 0.0003
910 RASH MACULAR 9 0.0003
911 BLOOD PRESSURE INCREASED 39 0.0003
912 MEMORY IMPAIRMENT 35 0.0003
913 HEADACHE 152 0.0002
914 MUSCLE SPASMS 43 0.0002
915 IRRITABLE BOWEL SYNDROME 5 0.0002
916 ARTHRITIS 18 0.0002
917 JOINT STIFFNESS 6 0.0002
918 FEELING HOT 14 0.0002
919 STEVENS-JOHNSON SYNDROME 5 0.0002
920 SOMNOLENCE 45 0.0002
921 SURGERY 13 0.0002
922 RESTLESSNESS 8 0.0002
923 BLOOD URINE PRESENT 4 0.0002
924 MENTAL DISORDER 9 0.0002
925 MENTAL IMPAIRMENT 5 0.0002
926 NASAL CONGESTION 12 0.0002
927 CONDITION AGGRAVATED 62 0.0002
928 HEART RATE INCREASED 20 0.0002
929 THERAPEUTIC PRODUCT EFFECT DECREASED 9 0.0002
930 SWELLING FACE 13 0.0002
931 OXYGEN SATURATION DECREASED 11 0.0002
932 ECZEMA 10 0.0002
933 LIP SWELLING 6 0.0002
934 FLUID RETENTION 9 0.0002
935 HALLUCINATION 13 0.0002
936 UNEVALUABLE EVENT 13 0.0002
937 LABORATORY TEST ABNORMAL 5 0.0002
938 SKIN BURNING SENSATION 12 0.0002
939 ROAD TRAFFIC ACCIDENT 7 0.0002
940 SINUSITIS 17 0.0002
941 OSTEOARTHRITIS 7 0.0002
942 HYPERHIDROSIS 21 0.0002
943 TREMOR 27 0.0002
944 PROSTATE CANCER 13 0.0002
945 LIMB DISCOMFORT 5 0.0002
946 ANGIOEDEMA 7 0.0002
947 DRUG DOSE OMISSION 26 0.0002
948 PRODUCT SUBSTITUTION ISSUE 9 0.0002
949 THROAT IRRITATION 7 0.0002
950 FEELING ABNORMAL 37 0.0002
951 THERAPY INTERRUPTED 11 0.0002
952 PRODUCT USE ISSUE 28 0.0001
953 DRUG EFFECT DECREASED 8 0.0001
954 DISTURBANCE IN ATTENTION 8 0.0001
955 DYSKINESIA 6 0.0001
956 HOT FLUSH 11 0.0001
957 OSTEOPOROSIS 6 0.0001
958 BLOOD GLUCOSE DECREASED 7 0.0001
959 ANAPHYLACTIC REACTION 8 0.0001
960 DIABETES MELLITUS 11 0.0001
961 BURNING SENSATION 10 0.0001
962 ADVERSE EVENT 13 0.0001
963 WEIGHT INCREASED 31 0.0001
964 VAGINAL HAEMORRHAGE 6 0.0001
965 SKIN IRRITATION 6 0.0001
966 INJURY 9 0.0001
967 SLEEP DISORDER 9 0.0001
968 INFLUENZA 14 0.0001
969 JOINT SWELLING 15 0.0001
970 BLOOD GLUCOSE INCREASED 23 0.0001
971 PALPITATIONS 14 0.0001
972 ASTHMA 13 0.0001
973 URTICARIA 19 0.0001
974 PRODUCT USE IN UNAPPROVED INDICATION 28 0.0001
975 ADVERSE DRUG REACTION 10 0.0001
976 FOETAL EXPOSURE DURING PREGNANCY 9 0.0001
977 ACCIDENTAL OVERDOSE 4 0.0001
978 MEDICATION ERROR 6 0.0001
979 RENAL CANCER 5 0.0001
980 MUSCULOSKELETAL STIFFNESS 9 0.0001
981 FLUSHING 10 0.0001
982 MOBILITY DECREASED 7 0.0001
983 AGITATION 7 0.0001
984 BRADYCARDIA 5 0.0001
985 CHRONIC KIDNEY DISEASE 7 0.0001
986 INFUSION RELATED REACTION 6 0.0001
987 OVERDOSE 19 0.0001
988 EMOTIONAL DISTRESS 10 0.0001
989 INFLUENZA LIKE ILLNESS 5 0.0001
990 NO ADVERSE EVENT 10 0.0001
991 BREAST CANCER 5 0.0001
992 MIGRAINE 5 0.0001
993 COVID-19 9 0.0001
994 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 10 0.0000
995 INJECTION SITE PAIN 6 0.0000